Archive: February, 2015

 

 

Saluda announces Series B funding

Saluda Medical secures $10 million in new financingNew funding secured for Saluda Medical is set to open the next chapter in commercialising breakthrough treatment of chronic pain.

Read more about Saluda announces Series B funding

BIOSCIENCE MANAGERS $5M CORNERSTONE INVESTMENT IN SALUDA MEDICAL

Leading healthcare fund manager BioScience Managers has invested $5 million in novel chronic pain treatment company Saluda Medical Pty Ltd.

Read more about BIOSCIENCE MANAGERS $5M CORNERSTONE INVESTMENT IN SALUDA MEDICAL